Shows
This Is Why with Dr. BustiSensitivity & Specificity Explained for Clinical PracticeSensitivity and specificity are some of the most misunderstood concepts in evidence-based medicine and diagnostic testing. In this episode of This Is Why with Dr. Busti, Dr. Busti breaks down the clinical meaning behind sensitivity, specificity, true positives, false positives, false negatives, and diagnostic accuracy using practical examples clinicians can immediately apply.This Is Why understanding sensitivity and specificity matters far beyond memorization. Dr. Busti explains how clinicians use highly sensitive tests to rule out disease and highly specific tests to rule in disease while also demonstrating how false positives and false negatives influence patient care decisions.
2026-06-2735 minThis Is Why with Dr. BustiDiagnostic Tests Explained: Precision & Accuracy in PracticeDiagnostic tests used in research and clinical practice are essential to evidence-based medicine because they shape how clinicians diagnose disease, interpret tests, and make patient care decisions. In this episode of This Is Why with Dr. Busti, Dr. Busti explains how the precision and accuracy of diagnostic studies are designed, validated, and critically appraised using clinically relevant examples and practical reasoning.This Is Why understanding sensitivity, specificity, predictive values, and likelihood ratios matters far beyond memorization. Dr. Busti walks through how clinicians determine whether a diagnostic test is useful, how bias affects study validity, and why gold-standard...
2026-06-2514 minThis Is Why with Dr. BustiDiagnostic Tests & Studies: How to Use & Evaluate in PracticeDiagnostic studies are foundational to evidence-based medicine because they help clinicians determine disease presence, severity, progression, and treatment response. In this episode of This Is Why with Dr. Busti, Dr. Busti explains the essential framework behind diagnostic studies, including sensitivity, specificity, predictive values, likelihood ratios, and critical appraisal tools used to evaluate study validity.This Is Why understanding diagnostic studies matters for every clinician. Dr. Busti breaks down how diagnostic assays are developed, validated, and interpreted using practical clinical examples, including troponins, HIV viral load monitoring, BNP in heart failure, and lactate clearance in sepsis....
2026-06-2240 minThis Is Why with Dr. BustiRegression Analysis Explained: Confounders & Clinical MeaningRegression analysis explained — understanding how variables influence outcomes is essential for interpreting clinical research in this episode of This Is Why with Dr. Busti.Dr. Busti breaks down regression analysis and how it helps identify relationships between variables while controlling for confounders. This Is Why mastering regression allows you to determine whether an intervention truly drives outcomes—or if other factors are influencing the results.You’ll learn the difference between linear and multivariate regression, how independent and dependent variables interact, and why controlling for confounders is critical for internal validity. Dr. Busti also connects regres...
2026-06-1826 minThis Is Why with Dr. BustiSUSPEND Trial | Tamsulosin for Kidney Stones ExplainedTamsulosin for kidney stones is one of the most commonly prescribed therapies for ureteral stones — but does it actually help? In this episode of This Is Why with Dr. Busti, we break down the landmark SUSPEND trial and explain why the answer depends on the patient, the stone size, and the clinical context.This Is Why many clinicians changed how they approach medical expulsive therapy after SUSPEND. But the real lesson is not simply whether to use tamsulosin — it’s understanding which patients are most likely to benefit and why later evidence refined the conversation.Dr. Bu...
2026-06-1319 minThis Is Why with Dr. BustiEpistaxis Explained Why Nosebleeds Happen | Dr. BustiEpistaxis explained by Dr. Busti. In this episode on This Is Why, we break down why epistaxis happens, how clinicians think through causes of bleeding, and why the location of bleeding matters clinically.Dr. Busti explains anterior vs posterior epistaxis, common risk factors, medication-related bleeding, vascular anatomy, and when recurrent nosebleeds may signal a more serious underlying condition.This episode connects anatomy, physiology, pathology, and clinical reasoning so healthcare professionals can better understand the “why” behind epistaxis and nosebleed management.Topics Covered:- What epistaxis means clinically- Why nosebleeds happen...
2026-06-0918 minThis Is Why with Dr. BustiEffect Size (Relative Risk (RR), Odds Ratio (OR), NNT/NNH) Made SimpleEffect size (Relative risk vs odds ratio vs hazard ratio & NNT and NNH explained — This Is Why understanding these concepts is essential for interpreting clinical trials with Dr. Busti.In this episode of This Is Why, Dr. Busti breaks down relative risk (RR), odds ratios (OR), absolute risk reduction (ARR), absolute risk increase (ARI), number needed to treat (NNT), and number needed to harm (MMH) in a way that connects directly to real clinical decision-making. This Is Why learning the “why” behind these calculations helps you move beyond memorization and actually apply evidence to patient care.Yo...
2026-06-0539 minThis Is Why with Dr. BustiD-Dimer Explained: When Suspected DVT Needs UltrasoundD-dimer explained for DVT evaluation. This Is Why healthcare professionals must understand what an elevated D-dimer actually means before jumping to conclusions. Dr. Busti walks through a common deep vein thrombosis scenario and explains why compression ultrasonography—not automatic anticoagulation—is the correct next step when DVT is suspected.Many learners incorrectly assume that an elevated D-dimer confirms a clot. Others memorize algorithms without understanding the clinical reasoning behind them. In this episode, Dr. Busti breaks down Wells score interpretation, pretest probability, D-dimer limitations, and how clinicians should approach suspected DVT in real-world practice.Whether you...
2026-06-0213 minThis Is Why with Dr. BustiNINDS Trial Explained Stroke Thrombolysis Risks and BenefitsStroke thrombolysis changed emergency neurology forever—but understanding why the NINDS trial mattered is what transforms memorization into clinical decision-making. In this episode of This Is Why with Dr. Busti, we break down the landmark NINDS rt-PA trial that established alteplase as a treatment for acute ischemic stroke and explore the real-world balance between functional recovery and intracerebral hemorrhage risk.Dr. Busti explains how to interpret the trial beyond headlines by walking through the study design, inclusion criteria, outcomes, NNT and NNH calculations, odds ratios, bleeding risk, and the evolution of thrombolytic therapy from alteplase to tenecteplase. Th...
2026-05-2730 minThis Is Why with Dr. Busti95% Confidence Intervals Explained for Medical LiteratureConfidence intervals are one of the most misunderstood concepts in evidence-based medicine. In this episode of This Is Why with Dr. Busti, we break down what 95% confidence intervals actually mean, how they relate to p values and effect size, and why they are essential for interpreting clinical research correctly.Dr. Busti walks through practical examples involving odds ratios, hazard ratios, relative risk, forest plots, and statistical significance so healthcare professionals can confidently evaluate published literature and apply evidence appropriately in clinical decision-making.Whether you're preparing for boards, learning research interpretation, or improving your evidence-based medicine...
2026-05-2527 minThis Is Why with Dr. BustiTinnitus Explained: Symptom vs DiagnosisTinnitus explained clearly—This Is Why it matters clinically with Dr. Busti. Understanding tinnitus as a symptom, not a diagnosis, changes how you think, communicate, and manage patients.In this episode, Dr. Busti breaks down the meaning of tinnitus, its clinical implications, and how proper terminology drives better clinical reasoning. From pathophysiology to medication causes and key descriptors like pulsatile and unilateral tinnitus, this is a foundational concept every healthcare professional must master.This Is Why terminology is more than vocabulary—it’s a tool for thinking.Topics Covered:- What tinnitus actual...
2026-05-2114 minThis Is Why with Dr. BustiP Values Explained Clearly: Statistical vs Clinical SignificanceP values explained clearly in clinical research — This Is Why understanding what a P value means (and does NOT mean) with Dr. Busti is critical for interpreting evidence and applying it to patient care.In this episode, Dr. Busti breaks down one of the most misunderstood concepts in biostatistics: the P value. You’ll learn exactly what a P value tells you about chance, random error, and statistical significance—and more importantly, what it does NOT tell you about clinical relevance.Using landmark clinical trials, including real-world examples, this episode connects statistical interpretation to actual patien...
2026-05-1929 minThis Is Why with Dr. BustiWhy Sulfonylureas Cause Hypoglycemia ExplainedWhy sulfonylureas cause hypoglycemia becomes much easier to understand once you know how pancreatic beta cells regulate insulin secretion. In this episode of This Is Why with Dr. Busti, we walk through a board-style pharmacology question that connects ATP-sensitive potassium channels, membrane depolarization, calcium influx, and insulin release into one clinically useful framework.Instead of memorizing isolated diabetes medication facts, this episode explains the physiology behind insulin secretagogues and why missed meals can become dangerous in patients taking sulfonylureas or meglitinides. Dr. Busti breaks down the mechanism step-by-step so you can reason through pharmacology questions, recognize common...
2026-05-1513 minThis Is Why with Dr. BustiCorrelation vs R Squared Explained This Is Why It MattersIn this episode on This Is Why, Dr. Busti breaks down one of the most commonly misunderstood biostatistics concepts: correlation vs coefficient of determination. You’ll learn how to interpret the correlation coefficient (r), what it actually tells you about relationships between variables, and why it does NOT imply causation.Then we connect that foundation to R² (coefficient of determination) — and This Is Why it’s critical for understanding how much variability one variable explains in another. Through clinical context and practical examples, you’ll see how these concepts apply to real-world decision-making, not just test...
2026-05-1313 minThis Is Why with Dr. BustiGISSI-3 Trial: ACE Inhibitors After MI ExplainedACE inhibitors after myocardial infarction — Dr. Busti explains the GISSI-3 trial and what it actually changed in clinical practice on this episode of This Is Why.After the initial management of acute MI, the real question becomes: what else improves survival and prevents long-term damage? The GISSI-3 trial tackled this directly, evaluating early ACE inhibitor therapy and routine nitrate use in a large, real-world population.Dr. Busti breaks down how lisinopril provided a modest but meaningful mortality benefit—and why that matters more than it seems. More importantly, we expl...
2026-05-1112 minThis Is Why with Dr. BustiBiostatistics Framework | Mean, Median, Mode Explained + SD vs SEMMean, median, mode, standard deviation, and standard error explained in the context of clinical research and data interpretation.In this This Is Why lecture, Dr. Busti walks through the core measures of central tendency and variability and shows how they relate to data type, study design, and proper interpretation.This is where many learners make mistakes—especially when interpreting skewed data, choosing between mean vs median, or understanding the difference between standard deviation and standard error.This episode builds directly on the Biostatistics Framework an...
2026-05-1123 minThis Is Why with Dr. BustiAmiodarone in Cardiac Arrest: ARREST Trial ExplainedAmiodarone in cardiac arrest — Dr. Busti breaks down the ARREST trial and what it actually means for patient outcomes in this episode of This Is Why.When ventricular fibrillation persists after multiple shocks, what’s the next step? The ARREST trial gave us one of the first randomized answers—but understanding the why behind the results is what truly changes how you practice.Dr. Busti walks through the evidence behind amiodarone in shock-refractory VF/pulseless VT, highlighting what improved—and what didn’t. You’ll learn how to interpret short-term survival benefits, weigh adverse effects, and apply th...
2026-05-0710 minThis Is Why with Dr. BustiMedical Terminology: SternutateWhat does “sternutate” actually mean, and why does medicine use complex terms for simple human experiences like sneezing? In this episode of This Is Why, Dr. Busti breaks down the medical term sternutate, its Latin origin, and how it connects to the physiology of sneezing as a protective reflex. This episode goes beyond memorization to focus on clinical reasoning—helping healthcare professionals understand how a common symptom like sneezing can point to underlying conditions such as allergic rhinitis, infections, or environmental triggers. If you want to better understand the “why” behind medical terminology and apply it to real p...
2026-05-0507 minThis Is Why with Dr. BustiPower Analysis Explained: Type II Error, Beta, and Sample SizePower analysis is essential for interpreting clinical research and determining whether a study can truly detect a meaningful difference.In this lecture on This Is Why, Dr. Busti will explain what statistical power really means, how it relates to beta and Type II error, and why sample size plays a critical role in identifying true differences in clinical studies. He walks through the conceptual meaning of power—not just the formula—and shows how clinicians and researchers should interpret study results when no difference is found.This lecture is part...
2026-05-0425 minThis Is Why with Dr. BustiAlpha Value Explained (Type I Error)| Biostatistics SeriesAlpha value and Type I error are foundational concepts in biostatistics and clinical research interpretation.In this lecture on This Is Why, Dr. Busti will explain what alpha represents, how it is determined, and how clinicians should interpret it when evaluating medical literature. This session clarifies the relationship between alpha, Type I error, hypothesis testing, and study power, helping learners connect statistical theory to real clinical decision-making.This lecture is part of the broader This Is Why evidence-based medicine series, where each concept builds on previous topics to strengthen...
2026-05-0118 minThis Is Why with Dr. BustiParametric vs Non-Parametric Statistical Tests ExplainedParametric vs Non-Parametric statistical tests are explained, and how they relate to data type, distribution, and study design.In this lecture on This Is Why, Dr. Busti brings the full biostatistics framework of the Statistical Analysis Plan (SAP) together—connecting data type, distribution, and study groups to the correct statistical analysis.Understanding when to use parametric vs. nonparametric tests is critical for interpreting clinical research and avoiding common mistakes when evaluating data in evidence-based medicine (EBM).This lecture reinforces how normal vs skewed data, ou...
2026-04-2715 minThis Is Why with Dr. BustiIndependent vs Paired Groups Explained (Choose the Right Test)Independent vs paired study groups explained and how they determine the correct statistical test in clinical research.In this This Is Why lecture, Dr. Busti breaks down one of the most important steps in biostatistics—identifying the type of study groups and how that directly impacts statistical test selection.Understanding whether groups are independent or related is essential for interpreting clinical trials and avoiding common mistakes when reading research.This lecture builds on prior topics and moves you closer to confidently choosing the correct st...
2026-04-2414 minThis Is Why with Dr. BustiPractice Question: Parkinson Disease Medication Discontinuation SafetyParkinson disease medication discontinuation safety is the focus of this episode of This Is Why with Dr. Busti. In this board-style practice question, we work through a clinical scenario involving adverse effects, medication management, and the reasoning process needed to approach discontinuation decisions safely in practice and on exams.In this episode, Dr. Busti breaks down how to think through a medication safety question step by step, identify common board traps, and connect the pharmacology to real patient care.Topics Covered:- Parkinson disease medication management
2026-04-2208 minThis Is Why with Dr. BustiTypes of Data Explained: Nominal, Ordinal, or Continuous?Types of data for a study's endpoint are explained—nominal, ordinal, or continuous—and how each determines the appropriate statistical test in clinical research.In this lecture on This Is Why, Dr. Busti walks through one of the most critical steps in biostatistics: correctly identifying the type of data based on the study question.This is where many learners make mistakes—especially when distinguishing between ordinal vs continuous data, recognizing skewed data, or understanding when to use parametric vs non-parametric analysis.This lecture connects direct...
2026-04-2027 minThis Is Why with Dr. BustiIntro to Biostatistics: How to Pick the Right Statistical TestHow do you choose the right statistical test in clinical research?In this This Is Why (TIW) lecture, Dr. Busti introduces the biostatistics decision-making framework that connects hypothesis, study design, and data type to the correct statistical analysis.This is not a memorization lecture—it’s about understanding the structure behind statistical choices so you can evaluate research correctly as a clinician or researcher.This episode sets the foundation for the entire Biostatistics Framework series, where each concept builds step-by-step into practical application.
2026-04-1729 minThis Is Why with Dr. BustiP2Y12 Inhibitors (ADP Inhibitors): Antiplatelet Pharmacology Made EasyIn this lesson on P2Y12 inhibitors (ADP inhibitors), you’ll learn the high-yield, test-relevant concepts behind the most common antiplatelet drugs used in cardiovascular care. In this lecture from This is Why, Dr. Busti will break down how platelet aggregation inhibitors work, when they’re used clinically, and the key differences between clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brilinta), and cangrelor (Kengreal)—so you can apply the “why” behind therapy (not just memorize drug names).You’ll learn how to:- The P2Y12 (ADP) receptor and how blocking it reduces platelet activation
2026-01-1644 minThis Is Why with Dr. BustiGPIIb/IIIa Inhibitors: Antiplatelet Pharmacology Made Easy & RelevantIn this lesson on glycoprotein (GP) IIb/IIIa (GPIIb/IIIa) inhibitors, you’ll learn the high-yield, test-relevant concepts behind the adjunct antiplatelet drug therapy used in the acute management of patients experiencing an acute myocardial infarction (AMI; NSTEMI, STEMI) and undergoing PCI or coronary stent placement. In this lecture from This is Why, Dr. Busti will break down how platelet aggregation inhibitors work, when they’re used clinically, and the key differences between tirofiban and eptifibatide —so you can apply the “why” behind therapy (not just memorize drug names).You’ll learn how to:- The G...
2026-01-1617 minThis Is Why with Dr. BustiAspirin (ASA): Antiplatelet Pharmacology Made Easy & RelevantMaster Aspirin (ASA) fast with this Antiplatelet Pharmacology Made Easy & Relevant lecture. In this lecture from This is Why, Dr. Busti will make sure you learn how acetylsalicylic acid works as an antiplatelet drug, including COX-1 inhibition, decreased thromboxane A2 (TXA2), and reduced platelet aggregation—plus the key clinical takeaways for MI prevention, stroke prevention, and secondary prevention.You’ll learn how to:- Aspirin mechanism of action (COX inhibitor → ↓ TXA2 → ↓ platelet aggregation)- Why aspirin is different from other NSAIDs in antiplatelet therapy- High-yield uses in cardiovascular pharmacology (MI/stroke prevention)- Side effec...
2026-01-1543 minThis Is Why with Dr. BustiHeparins (UFH & LMWH): Pharmacology Made Easy & Clinically RelevantIn this lecture from This is Why, Dr. Busti will break down Heparin (UFH) and Low-Molecular-Weight Heparins (LMWHs), such as enoxaparin (Lovenox) and dalteparin (Fragmin), with a clear, clinically relevant approach. If you’re studying anticoagulation or need a fast refresher on anticoagulants, this video is for you.In this lesson, you’ll learn:- Heparin mechanism of action (UFH vs LMWH) + how they work in the clotting cascade- Monitoring & labs: aPTT/PTT for UFH, anti–Factor Xa concepts for LMWH- Dosing/administration pearls (IV vs SQ, onset/offset, bridging basics)- Adve...
2026-01-141h 00This Is Why with Dr. BustiWarfarin (Vitamin K Antagonist; VKA): Pharmacology Made EasyWarfarin (Vitamin K Antagonist; VKA) doesn’t have to be confusing. In this lecture from This is Why, Dr. Busti will explain warfarin's (Coumadin) pharmacology in a simple, clinically relevant way. It is perfect for anyone reviewing anticoagulation.You’ll learn how to:- Mechanism of action: how warfarin works as a vitamin K antagonist (VKA) (VKOR inhibition)- What PT/INR measures and why INR monitoring matters- How to start warfarin dosing (and what affects dose response)- Bridging with heparin/LMWH (warfarin bridge / heparin bridge) and when it’s needed...
2026-01-1437 minThis Is Why with Dr. BustiFactor Xa inhibitors (DOACs): Pharmacology Made Easy & RelevantFactor Xa inhibitors (DOACs) made easy—fast, clear, and clinically relevant. In this lecture from This is Why, Dr. Busti will break down direct oral anticoagulants (DOACs) and how Factor Xa inhibitors work, with relevance.You’ll learn how to:- What Factor Xa inhibitors do (mechanism of action)- Key drugs: Apixaban (Eliquis), Rivaroxaban (Xarelto), Edoxaban (Savaysa)- Common indications: Afib stroke prevention, DVT/PE treatment- Major adverse effects and safety: bleeding risk, interactions, and monitoring pearls- Reversal overview: What to know + when it mattersThe goal = make...
2026-01-1436 minThis Is Why with Dr. BustiDirect Thrombin inhibitors (DTI): Pharmacology Made Easy & RelevantDirect Thrombin Inhibitors (DTIs) made simple and clinically relevant! In this lecture from This is Why, Dr. Busti will help you master direct thrombin (Factor IIa) inhibitors—including the oral DTI dabigatran (Pradaxa) and key parenteral DTIs like bivalirudin (and where argatroban fits clinically, especially in the acute care setting)You’ll learn how to:- Where direct thrombin inhibitors work in the coagulation cascade- How dabigatran works (mechanism of action), major indications, and high-yield adverse effects- What to monitor, common drug interactions, and who is at higher bleeding risk- Dabi...
2026-01-1338 minThis Is Why with Dr. BustiCommunity-Acquired Pneumonia (CAP): Made Easy & Clinically RelevantIn this lecture from This is Why, Dr. Busti will make Community-Acquired Pneumonia (CAP) simple, practical, and clinically relevant—so you can confidently recognize CAP, assess severity, and choose the right pneumonia treatment.What you’ll learn:- How to approach CAP pneumonia like a clinician: presentation, diagnosis, and key differentials- How to assess severity using CURB-65 and the Pneumonia Severity Index (PSI score)- How to decide outpatient pneumonia vs inpatient pneumonia management- How to choose CAP antibiotics with guideline-based empiric antibiotics pneumonia sele...
2026-01-051h 01This Is Why with Dr. BustiAtrial Fibrillation: Made Easy & Clinically RelevantAtrial fibrillation (AFib) made easy—clinically relevant ECG/EKG interpretation, how to recognize AFib with RVR, and how to approach AFib management from bedside to boards.In this lecture from This is Why, Dr. Busti will , Dr. Busti breaks down atrial fibrillation in a clear, practical way so you can confidently answer:- What is AFib and why does it matter clinically?- How do you identify AFib on an ECG/EKG (classic “irregularly irregular” rhythm)?- When is it atrial fibrillation with RVR and what do you do fir...
2026-01-011h 08
ghossywhawogRead online: Kern's Cardiac Catheterization Handbook by Paul Sorajja MD, FACC, FAHA, FSCAI, Michael J Lim MD, FACC, FSCAIBook Kern's Cardiac Catheterization Handbook PDF Download - Paul Sorajja MD, FACC, FAHA, FSCAI, Michael J Lim MD, FACC, FSCAI Get ebook ➡ https://masterbooo.firebaseapp.com/fs/book/763736/1461 Read Online Kern's Cardiac Catheterization Handbook Free Book (PDF eƤub Mobi) by Paul Sorajja MD, FACC, FAHA, FSCAI, Michael J Lim MD, FACC, FSCAI Kern's Cardiac Catheterization Handbook Paul Sorajja MD, FACC, FAHA, FSCAI, Michael J Lim MD, FACC, FSCAI PDF, Kern's Cardiac Catheterization Handbook Paul Sorajja MD, FACC, FAHA, FSCAI, Michael J Lim MD, FACC, FSCAI eƤub Windows, Kern's Card...
2025-12-3100 min
AWR Malagasy / Malgache1 - Mitia sy mikolokolo no fanafody tsara indrindra 2 - Didy 12 ray aman-dreny sny ny mpanabe faha sivy ambinifolo 3- Atsory ny tanana1 - Mitia sy mikolokolo no fanafody tsara indrindra 2 - Didy 12 ray aman-dreny sny ny mpanabe faha sivy ambinifolo 3- Atsory ny tanana
2025-12-3059 minThis Is Why with Dr. BustiSulfa Allergy: What Drugs to Avoid (and What’s Usually Safe)Sulfa allergy is one of the most commonly reported drug allergies (often cited around ~6% of patients), and it frequently leads clinicians to avoid entire medication classes—sometimes unnecessarily. In this lecture from This is Why, Dr. Busti will break down what drugs to avoid with a sulfa allergy (and what’s usually safe) by focusing on the “why”: the chemical features that drive true sulfonamide allergy risk and what that means for real-world prescribing.You’ll learn how to:- Identify what makes a drug a “sulfonamide”- Distinguish antimicrobial vs non-antimic...
2025-12-2713 min